Supplementary Table 1. General information of 8 patients

No. / Age ( year) / Histology / FIGO Stage / Lymph node metastasis
1 / 47 / Serous / III / Yes
2 / 48 / Clear / III / NA
3 / 76 / Endometrioid / I / No
4 / 31 / Clear / I / No
5 / 66 / Serous / I / No
6 / 55 / Serous / III / Yes
7 / 56 / Serous / III / No
8 / 55 / Serous / III / No

Supplementary Table 2. General information of the cell lines

Cell lines / Histology / Origin
Caov-3 / serous / Duke
Hey / serous / Duke
OV90 / serous / Duke
A1847 / serous / Duke
OVCA420 / serous / Duke
OVCA429 / serous / Duke
OVCA433 / serous / Duke
OVCAR-3 / serous / Kyoto
SKOV3 / serous / Kyoto
JHOC-5 / Clear / Riken
JHOC-7 / Clear / Riken
JHOC-8 / Clear / Riken
JHOC-9 / Clear / Riken
OVISE / Clear / Yokohama city
OVTOKO / Clear / Yokohama city
RMG-Ⅴ / Clear / Keio
TAYA / Clear / Jichi
TOV-21G / Clear / Duke
A2008 / endometrioid / Duke
C13 / endometrioid / Duke
IGROV1 / endometrioid / Duke
FUOV1 / endometrioid / Duke
OV2008 / endometrioid / Duke
TOV-112D / endometrioid / Duke
MCAS / Mucinous / Kyoto
A2780 / undifferentiated / Kyoto
A2780 cisR / undifferentiated / Kyoto
BG1 / undifferentiated / Duke
OVCAR8 / undifferentiated / Duke
PEO1 / undifferentiated / Duke
PEO4 / undifferentiated / Duke
TYK-nu / undifferentiated / Kyoto
Tyk-nu cisR / undifferentiated / Kyoto
OSE6 / Normal / Duke
OSE7 / Normal / Duke

Kyoto, stored in our department; Duke, provided from Duke University Medical Center, USA; Keio, Keio University, Japan; Jichi, Jichi Medical University, Japan; Yokohama, Yokohama City University, Japan; Riken, purchased from Riken, Japan

1